Assistant Professor of Radiation Oncology, Massachusetts General Hospital
Radiation Oncology
Dr. David T. Miyamoto, MD
|
|
Give Review
David Miyamoto is an expert in the field of Radiation Oncology. He went to Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Doctor David T. Miyamoto, MD is a published physician as well. He has 18 publications published. The latest was: Deformability-based cell selection with downstream immunofluorescence analysis. He is registered with Medicare and accepts Medicare payments.
Publications
- Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells.
- Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer.
- Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.
- Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.
- Circulating tumour cells-monitoring treatment response in prostate cancer.
- Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.
- Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.
- A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases.
- Molecular predictors of local tumor control in early-stage breast cancer.
- Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.
- Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.
- The kinesin Eg5 drives poleward microtubule flux in Xenopus laevis egg extract spindles.
- XRHAMM functions in ran-dependent microtubule nucleation and pole formation during anastral spindle assembly.
- Layering defect in p35 deficiency is linked to improper neuronal-glial interaction in radial migration.
- Dynamics of the mitotic spindle--potential therapeutic targets.
- Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis.
- Deformability-based cell selection with downstream immunofluorescence analysis.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Harvard Medical School
Hospital
-
Emerson Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1689724171 | |
| NPPES Provider LastName | MIYAMOTO | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 021142606 | |
| NPPES Provider State | MA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 19.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689724171 |
| Last Name Of The Provider | MIYAMOTO |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. John E. Munzenrider, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kristina L. Mirabeau-Beale, MD |
|
|
Dr. Stephen A. Mihalcik, MD |
|
|
Dr. Rachel Jimenez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamed E. Abazeed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kent W. Mouw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann C. Raldow, MD |
|
|
Dr. Andrea L. Russo, MD |
|
|
Dr. Michael E. Pacold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tai C. Lam, MD |
|
|
Dr. Aaron M. Allen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott R. Floyd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil E. Martin, MD |
|
|
Dr. Lisa A. Kachnic, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|